Search details
1.
Merits and boundaries of the BCLC staging and treatment algorithm: Learning from the past to improve the future with a novel proposal.
J Hepatol
; 80(4): 661-669, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38266658
2.
Novel endoscopic scoring system for immune mediated colitis: A Multicenter Retrospective Study of 674 Patients.
Gastrointest Endosc
; 2024 Jan 23.
Article
in English
| MEDLINE | ID: mdl-38272276
3.
The Hammersmith Score optimises patient selection and predicts for overall survival in early-phase cancer trial participants independent of tumour burden.
Chemotherapy
; 2024 Apr 27.
Article
in English
| MEDLINE | ID: mdl-38679017
4.
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept.
Lancet Oncol
; 24(7): e312-e322, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37414020
5.
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study.
Hepatology
; 76(4): 1000-1012, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35313048
6.
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.
Liver Int
; 43(3): 695-707, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36577703
7.
Consensus report from the 10th Global Forum for Liver Magnetic Resonance Imaging: developments in HCC management.
Eur Radiol
; 33(12): 9152-9166, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37500964
8.
Consensus report from the 10th global forum for liver magnetic resonance imaging: multidisciplinary team discussion.
Eur Radiol
; 33(12): 9167-9181, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37439935
9.
PETAL protocol: a phase Ib study of pembrolizumab after transarterial chemoembolization in hepatocellular carcinoma.
Future Oncol
; 19(7): 499-507, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-37097715
10.
The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study.
Int J Mol Sci
; 24(2)2023 Jan 16.
Article
in English
| MEDLINE | ID: mdl-36675262
11.
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study.
Lancet Oncol
; 23(7): 865-875, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35660139
12.
Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer.
Br J Cancer
; 127(10): 1787-1792, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35995934
13.
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score.
J Hepatol
; 76(2): 353-363, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34648895
14.
T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma.
J Hepatol
; 77(2): 397-409, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35367533
15.
Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity.
J Transl Med
; 20(1): 582, 2022 Dec 12.
Article
in English
| MEDLINE | ID: mdl-36503532
16.
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma.
Liver Int
; 42(11): 2538-2547, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35986902
17.
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study.
Liver Int
; 42(8): 1891-1901, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35608939
18.
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer.
BJU Int
; 130(5): 592-603, 2022 11.
Article
in English
| MEDLINE | ID: mdl-34597472
19.
New Frontiers in the Medical Therapy of Hepatocellular Carcinoma.
Chemotherapy
; 67(3): 164-172, 2022.
Article
in English
| MEDLINE | ID: mdl-34999584
20.
Safety and efficacy of percutaneous radiofrequency ablation for hepatocellular carcinoma: a textbook outcome analysis.
HPB (Oxford)
; 24(5): 664-671, 2022 05.
Article
in English
| MEDLINE | ID: mdl-34642089